Title:
ＨＩＶ−１阻害剤としてのＣ−３およびＣ−１７修飾トリテルペノイド
Document Type and Number:
Japanese Patent JP6735837
Kind Code:
B2
Abstract:
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I:These compounds are useful for the treatment of HIV and AIDS.
Inventors:
Chen, Gee
Chen, Yang
Dicker, Irabee.
Hearts, Richard A
Meanwell, Nicholas A
Nowika-Sands, Vita
Regeiro-Ren, Alicia
Sit, Shin-Yuen
Shin, Knee
Swidolski, Jacob
Venables, Brian Lee
Chen, Yang
Dicker, Irabee.
Hearts, Richard A
Meanwell, Nicholas A
Nowika-Sands, Vita
Regeiro-Ren, Alicia
Sit, Shin-Yuen
Shin, Knee
Swidolski, Jacob
Venables, Brian Lee
Application Number:
JP2018540806A
Publication Date:
August 05, 2020
Filing Date:
February 02, 2017
Export Citation:
Assignee:
Veeve Health Care UK (No. 5) Limited
International Classes:
C07J63/00; A61K31/44; A61K31/541; A61P31/18; C07K19/00
Domestic Patent References:
| JP2017510659A | ||||
| JP2016507558A | ||||
| JP2015501846A |
Attorney, Agent or Firm:
Hiraki International Patent Office